CYP2C8 GWAS Links CYP2C19 to Plavix Response; Randomized-Controlled Trial, PGx Consortium to Come Premium Following the GWAS, researchers plan to conduct a prospective, randomized-controlled trial and form a pharmacogenomics consortium specifically focused on validating and discovering new gene-response variants for clopidogrel. Breaking News Complete Genomics, Velsera Strike Deal to Integrate Sequencing, Data Analysis Techs EntroGen Colorectal Cancer RAS Mutation Detection Test Nabs CMS Coverage Prostate Cancer Study Leads to Prediction Models Based on Proteins in Blood, Urine Pacific Biosciences Licenses DNA Methylation Detection Tech from Chinese University of Hong Kong AccuStem Sciences Partners With EmeritusDx on Molecular Lung Cancer Screening Test
